Matches in Wikidata for { <http://www.wikidata.org/entity/Q64268305> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q64268305 description "article scientifique publié en 2019" @default.
- Q64268305 description "articolo scientifico (pubblicato il 2019)" @default.
- Q64268305 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q64268305 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q64268305 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64268305 description "scientific article published on 01 February 2019" @default.
- Q64268305 description "wetenschappelijk artikel" @default.
- Q64268305 description "наукова стаття, опублікована в лютому 2019" @default.
- Q64268305 name "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 name "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 name "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 type Item @default.
- Q64268305 label "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 label "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 label "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 prefLabel "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 prefLabel "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 prefLabel "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 P1433 Q64268305-AB622543-DC2C-4414-A7A6-0886A5FD3D89 @default.
- Q64268305 P1476 Q64268305-B4914B16-575D-46BD-AE3A-A5D971E8D2E1 @default.
- Q64268305 P2093 Q64268305-2DC80330-6321-4CF0-89C3-A64F3B025C96 @default.
- Q64268305 P2093 Q64268305-BE0B1FFC-5047-4D03-8DA4-8AB2D3A233C5 @default.
- Q64268305 P304 Q64268305-96E87ABC-A792-41FB-B242-99BAF210E87F @default.
- Q64268305 P31 Q64268305-11F4A998-48F8-4572-A917-6535442E846F @default.
- Q64268305 P356 Q64268305-ABCD3928-986C-445C-9AFA-B3E4EE0EA762 @default.
- Q64268305 P407 Q64268305-5B2BD33F-6696-4F22-B5EC-B48D46F69158 @default.
- Q64268305 P433 Q64268305-63E35D18-C33F-460A-9650-937F11F1572F @default.
- Q64268305 P478 Q64268305-CFCFC6D5-A984-4A54-BAC3-127A1F50E04B @default.
- Q64268305 P50 Q64268305-400E9B8F-07D9-417E-A70A-F06C830360E8 @default.
- Q64268305 P50 Q64268305-40A26B52-AE37-4E12-9585-EA4169B9F799 @default.
- Q64268305 P50 Q64268305-94496EF5-CDAC-4747-8D23-32EEB1449FD1 @default.
- Q64268305 P50 Q64268305-9676C255-AC3C-4801-90C3-DC8021C8AB39 @default.
- Q64268305 P50 Q64268305-B1297D1F-6748-4F2E-97EC-49953431BC39 @default.
- Q64268305 P50 Q64268305-C15243ED-45AF-4FC1-B26A-5F403F4188F4 @default.
- Q64268305 P577 Q64268305-A4DE0DEA-7EED-42E4-B39C-FA2262100FEE @default.
- Q64268305 P698 Q64268305-742141C5-B3E8-4BB9-BA43-8FBE8532195C @default.
- Q64268305 P921 Q64268305-1A2A9E19-4F1B-437F-93D3-1D2DEC3C46C4 @default.
- Q64268305 P921 Q64268305-2E5FC9EF-67E9-4C94-82F4-7243CD5AB47A @default.
- Q64268305 P921 Q64268305-5F9C08DA-CCF6-42CA-91C9-65858431299E @default.
- Q64268305 P932 Q64268305-D25346FB-E6D6-4E0E-925F-8F9BA7365899 @default.
- Q64268305 P356 HTA23080 @default.
- Q64268305 P698 30821231 @default.
- Q64268305 P1433 Q15708880 @default.
- Q64268305 P1476 "Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model" @default.
- Q64268305 P2093 "Jonathan Wadsley" @default.
- Q64268305 P2093 "Laura Moss" @default.
- Q64268305 P304 "1-144" @default.
- Q64268305 P31 Q13442814 @default.
- Q64268305 P356 "10.3310/HTA23080" @default.
- Q64268305 P407 Q1860 @default.
- Q64268305 P433 "8" @default.
- Q64268305 P478 "23" @default.
- Q64268305 P50 Q54087230 @default.
- Q64268305 P50 Q83234371 @default.
- Q64268305 P50 Q87657745 @default.
- Q64268305 P50 Q89475646 @default.
- Q64268305 P50 Q90366923 @default.
- Q64268305 P50 Q92032427 @default.
- Q64268305 P577 "2019-02-01T00:00:00Z" @default.
- Q64268305 P698 "30821231" @default.
- Q64268305 P921 Q1282091 @default.
- Q64268305 P921 Q1504425 @default.
- Q64268305 P921 Q826522 @default.
- Q64268305 P932 "6421509" @default.